Trials / Completed
CompletedNCT02060786
Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Ajou University School of Medicine · Academic / Other
- Sex
- All
- Age
- 19 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
This study demonstrates the effect of generic clopidogrel bisulfate (Plavitor®) in comparison with the original clopidogrel bisulfate (Plavix®) in patients with acute coronary syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | generic clopidogrel (Plavitor® ) | |
| DRUG | original clopidogrel (Plavix® ) |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2014-02-12
- Last updated
- 2014-02-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02060786. Inclusion in this directory is not an endorsement.